FINWIRES · TerminalLIVE
FINWIRES

US Equity Indexes Mixed Amid Anticipated Iran Peace Talks, Expected Hot Inflation

-- US equity indexes were mixed in Friday's midday trading as a fragile Iran truce looked set to hold until peace talks begin in Pakistan on Saturday, while a red-hot inflation read was in line with the outlook.

The Nasdaq Composite rose 0.3% to 22,887.1, while the S&P 500 fell 0.2% to 6,814.3 and the Dow Jones Industrial Average slid 0.6% to 47,881.5. Technology and materials were among the gainers, while consumer staples, health care, and financials led the decliners.

A key aim of the Iran peace talks in Islamabad is to fully reopen the Strait of Hormuz, where President Donald Trump said Thursday that Iran is "doing a very poor job" of letting crude oil pass and cautioned against collecting tolls in the strategic waterway, the report said.

Iran's parliament speaker, Mohammad Bagher Ghalibaf, said talks cannot start until the US meets two conditions: a ceasefire in Lebanon and the release of blocked Iranian assets.

Vice President JD Vance, setting off for US-Iran talks in Pakistan's capital Islamabad, said Washington is "willing to extend the open hand" in this weekend's negotiations but warned Tehran not to "try to play us," The Wall Street Journal said.

Ambassadors from Israel, Lebanon, and the US will hold talks in Washington, DC, on Friday to set the table for future negotiations between Israel and Lebanon, an Israeli official and a source familiar with the talks told CNN. The initial discussions will target an agreement on the agenda for direct negotiations, which Israel said would be aimed at disarming Hezbollah and establishing "peaceful relations" between the two countries.

West Texas Intermediate crude oil futures advanced 1% to $98.92, and Brent crude futures climbed 1.3% to $97.08.

In economic news, US consumer inflation accelerated to its highest monthly reading in nearly four years in March as the Middle East conflict sent energy prices sharply higher.

The consumer price index advanced 0.9% last month, its strongest pace of growth since June 2022, the Bureau of Labor Statistics reported Friday. The latest print met a Bloomberg-polled consensus view. Prices rose 0.3% in February. Annually, inflation grew to 3.3% from February's 2.4% rise, falling short of Wall Street's 3.4% projection.

Energy price growth jumped about 11% sequentially in March, led by a 21% surge in gasoline, accounting for nearly three-quarters of the headline increase, official data showed.

US Treasury yields rose, with the 10-year up 2.6 basis points to 4.32% and the two-year climbed 2.5 basis points to 3.81%.

"The fallout of the US/Israel-Iran war was evident in the March consumer price index," Oxford Economics Lead US Economist Bernard Yaros said in remarks emailed to.

In company news, Barclays adjusted its price target for Fair Isaac's (FICO) shares to $1,950 from $2,400 while maintaining its overweight rating. The stock traded down 14% intraday, among the steepest decliners on the SP 500.

In precious metals, gold futures fell 0.7% to $4,784.9 and silver futures slipped 0.3% to $76.22.

Related Articles

Research

Research Alert: Hca: Share Repurchases Help Q1 Eps Meet Estimates Despite Volume Pressures

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:HCA Healthcare delivered Q1 2026 EPS of $7.15, in line with consensus and up 10.9% Y/Y, while revenue of $19.109B grew 4.3% and beat the $19.07B consensus estimate. Same-facility admissions rose 1.3%, though surgical volumes declined with inpatient and outpatient surgeries down 0.3% and 1.7%, respectively, reflecting softness in elective procedures and seasonal headwinds. Strong share repurchase activity of $1.571B during the quarter supported EPS growth despite volume pressures. Management reaffirmed 2026 guidance ranges, indicating confidence in navigating policy headwinds. Adjusted EBITDA margin compressed 50 bps to 19.9% due to challenging volumes and inflationary cost pressures, though operating cash flow surged 22% to $2.014B. We view the continued strong cash generation and $9.179B remaining share repurchase authorization as supportive of capital returns despite headwinds from ACA enhanced premium tax credit expirations and OBBBA Medicaid funding cuts.

$HCA
Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of Intel Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our target price to $100 from $75, on a P/E of 33.3x our 2028 EPS, above peers/historical to reflect our view of upside to margins/estimates. After the better than expected Q1/Q2 guide, we lift our 2026 EPS to $1.05 from $0.70, 2027 to $1.40 from $1.30, and 2028 to $3.00 from $2.64. We expect INTC's revenue trajectory to benefit from greater content share in AI servers, where the CPU-to-accelerator ratio is moving from 1:8 back toward 1:4 or potentially parity, driven by inference, agentic AI, and physical AI workloads that are more CPU-intensive. This positions the Xeon franchise for strong, sustainable demand, with a product pipeline that is ramping the fastest in five years. Within the client segment, AI PCs are now over 60% of the client CPU mix. We are also encouraged by Intel Foundry momentum amid leading-edge wafer capacity shortages, with the Elon Musk Terafab partnership and multi-year long-term agreements with Google providing major endorsements. Intel 18A process yields are tracking well.

$INTC
Research

Research Alert: CFRA Keeps Hold Rating On Shares Of Bread Financial Holdings, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price to $96 from $79, 7.8x our 2027 EPS view vs. BFH's three-year historical forward P/E average of 6.2x and the peer average of 7.1x. We increase our 2026 EPS estimate to $11.30 from $9.70 and 2027's to $12.30 from $11.62, reflecting the company's significant Q1 earnings beat and the substantial impact of an accelerated share repurchase program. A key win from Q1 was the company's return to loan growth, reversing prior-period declines with a 2% Y/Y increase in end-of-period loans. This inflection was underpinned by robust consumer activity, with credit sales accelerating to 7% growth. Furthermore, credit metrics continued their gradual improvement, with the delinquency rate falling to 5.6% and the net loss rate decreasing to 7.3%. Management prudently maintained its 2026 outlook for low single-digit growth in both average loans and revenue, with net loss rate guidance of 7.2%-7.4%, a move we believe wisely accounts for ongoing macroeconomic uncertainty and geopolitical tensions.

$BFH